Copyright
©The Author(s) 2026.
World J Psychiatry. Jan 19, 2026; 16(1): 113064
Published online Jan 19, 2026. doi: 10.5498/wjp.v16.i1.113064
Published online Jan 19, 2026. doi: 10.5498/wjp.v16.i1.113064
Table 1 The inclusion criteria and exclusion criteria of each group
| Group | Inclusion criteria | Exclusion criteria |
| MDD-OB | (1) Outpatients meeting DSM-5 diagnostic criteria for MDD, with current MDE confirmed through the M.I.N.I 5.0 by trained psychiatrists; (2) HAMD-24 score ≥ 20; (3) First-episode, antidepressant-naive status at enrollment; and (4) BMI1 ≥ 28 kg/m2 | (1) Presence of organic brain diseases; (2) Severe systemic diseases; (3) Intellectual disability (or: Mental retardation); (4) History of alcohol or substance abuse; (5) Visual or auditory impairments; (6) History of clinically diagnosed neurological disorders; and (7) Pregnant or lactating women |
| MDD | (1) Outpatients meeting DSM-5 diagnostic criteria for MDD, with current MDE confirmed through the M.I.N.I 5.0 by trained psychiatrists; (2) HAMD-24 score ≥ 20; (3) First-episode, antidepressant-naive status at enrollment; and (4) 18.5 ≤ BMI < 24 kg/m2 | |
| OB | (1) BMI ≥ 28 kg/m2; and (2) Exclusion of MDD and other conditions meeting exclusion criteria | |
| HC | (1) 18.5 ≤ BMI < 24 kg/m2; and (2) Exclusion of MDD and other conditions meeting exclusion criteria | |
| All participant groups | (1) Minimum education level: Completion of elementary school or higher; (2) Aged 18-60 years, irrespective of gender; and (3) Voluntary participation with written informed consent obtained after full explanation of study procedures |
Table 2 Demographic features of participants in the study, n (%)
| Variables | HC (n = 37) | OB (n = 42) | MDD (n = 47) | MDD-OB (n = 23) | F/χ2 | P value | Post-hoc analysis |
| Age | 40.92 (8.61) | 38.6 (9.21) | 38.11 (12.99) | 34 (11.02) | 2.10 | 0.104 | |
| Sex (male/female) | 14/23 | 23/19 | 23/24 | 7/16 | 5.02 | 0.171 | |
| BMI | 23.24 (2.12) | 30.96 (2.48) | 22.36 (2.97) | 33.14 (8.85) | 61.01 | < 0.001 | OB > HC, MDD; MDD-OB > HC, OB, MDD-OB |
| HAMD-24 | 1.946 (2.95) | 4.048 (6.77) | 29.617 (11.33) | 26.08 (14.101) | 93.83 | < 0.001 | MDD > HC, OB; MDD-OB > HC, OB |
| Behavioral activation/inhibition | |||||||
| BASR | 12.81 (1.74) | 13.41 (1.68) | 11.51 (2.59) | 12.22 (1.91) | 6.51 | < 0.001 | HC > MDD; OB > MDD, MDD-OB |
| BASD | 11.39 (2.20) | 17.41 (1.70) | 15.51 (2.23) | 15.87 (2.88) | 49.52 | < 0.001 | OB > HC, MDD, MDD-OB; MDD > HC; MDD-OB > HC |
| BASF | 14.28 (2.54) | 20.03 (2.07) | 18.33 (2.58) | 19.35 (2.37) | 40.32 | < 0.001 | OB > HC, MDD; MDD > HC; MDD-OB > HC |
| BIS | 14.44 (2.01) | 19.82 (2.42) | 20.11 (3.39) | 21.04 (2.23) | 43.15 | < 0.001 | OB > HC; MDD > HC; MDD-OB > HC |
| Mean FD_Jenkinson1 | 0.8 (0.04) | 0.11 (0.07) | 0.09 (0.06) | 0.11 (0.06) | 2.10 | 0.102 | |
Table 3 Brain areas with significantly different regional homogeneity values among healthy control, obesity, major depressive disorder, and comorbid major depressive disorder-obesity groups
| Brain | Peak MNI Coordinates | F | Cluster size | ||
| X | Y | Z | |||
| MTG.L | -57 | -39 | 0 | 24.67 | 59 |
| Cuneus.R | 3 | -84 | 36 | 28.39 | 36 |
| Precuneus.L | -6 | -78 | 45 | 29.6 | 50 |
| Thalamus.L | -15 | -27 | 0 | 25.05 | 26 |
- Citation: Hou XF, Mei BH, Wang X, Zhao FT, He L, Chen QY, Zang C, Wang C, Tang YF, Li XX, Zhang HF, Wang N, Cao B. Abnormal regional spontaneous brain activity in major depressive disorder with obesity comorbidity: A resting-state functional magnetic resonance imaging study. World J Psychiatry 2026; 16(1): 113064
- URL: https://www.wjgnet.com/2220-3206/full/v16/i1/113064.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i1.113064
